Safety
Naltrexone blocks opioids: taking it while using opioids can bring on sudden withdrawal, and it stops opioid pain medicine from working. Naltrexone labels also warn about liver injury and a higher risk of overdose if opioids are used after stopping it. In the 12-month trial, side effects were mostly mild and short-lived, and about as common as on placebo.
Talk to a licensed clinician about your health history and every medication you take before you start.
Legal status
Prescription only; the ingredient has an FDA-approved form, but compounded versions are not FDA-approved, and this use is off-label. Low-dose naltrexone (LDN) is prepared by a compounding pharmacy for an individual prescription. Compounded products are not FDA-approved, and the FDA does not review them for safety, effectiveness or quality. Its use for longevity is off-label: a use the FDA label does not cover, which a clinician may still choose. Naltrexone is FDA-approved at 50 mg; low-dose versions are compounded from it for individual prescriptions under section 503A. The low-dose uses have not been reviewed by the FDA. Naltrexone is not a controlled substance.
What low-dose naltrexone (LDN) is
Low-dose naltrexone (LDN) contains naltrexone hydrochloride. Low doses (about 0.5 mg to 4.5 mg) are compounded from approved naltrexone and prescribed off-label.
What the FDA has approved
- Naltrexone 50 mg tablets and Vivitrol injection are approved for alcohol dependence and for blocking the effects of opioids
- No low-dose product is approved
Dosing
Capsule, tablet or troche, once a day in the trials below; your prescriber sets the schedule. Usually 0.5 mg to 4.5 mg a day. Clinics we checked sell 1 mg to 4.5 mg capsules; the trials below used 4.5 mg.
How well it works
Evidence is mostly about pain, not aging, and recent trials are negative. In a crossover trial of 58 people with fibromyalgia, 4.5 mg a day did not reduce pain or symptom scores more than placebo (Bested 2023). A 12-month trial in 98 women with fibromyalgia found no clinically meaningful benefit (INNOVA, 2026). No trial has tested LDN for aging or lifespan. Individual results vary.
Low-dose naltrexone (LDN) cost
Prices vary by clinic.